Please login to the form below

Not currently logged in
Email:
Password:

Bausch & Lomb allows bid rival to discuss offer with shareholders

Bausch & Lomb grants rival bidder Advanced Medical Optics (AMO) ìlimited permissionî to discuss its USD 4.2bn take over offer with selected shareholders

Bausch & Lomb has granted rival bidder Advanced Medical Optics (AMO) ìlimited permissionî to discuss its USD 4.2bn take over offer with selected shareholders.

The German ophthalmology company is staying with the original USD 3.7bn buyout deal from New York-based private equity firm, Warburg Pincus.

Bausch & Lomb says it is 'uncertain' that Advanced Medical Optics, which is the third largest lens solution manufacturer after Alcon and Bausch & Lomb, could win shareholder approval for its cash-and-stock counter bid.

Advanced Medical's third-largest shareholder, San Francisco-headquartered ValueAct Capital, has already opposed the takeover.

According to media reports, Bausch & Lomb has continued to recommend the pending purchase offer from Warburg Pincus in a letter from the board sent on 29 July to Advanced Medical's CEO, James V Mazzo.

The letter gives Advanced Medical until 12pm on 3 August to provide evidence of its ability to secure approval from stockholders.

31st July 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics